Showing results (351-360 of 472) with videos related to
Sort By:
Pageof 48
American Journal of Hematology|November 1, 2002
Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemiaHendrik W van Deventer, Melissa D Hall, Robert Z Orlowski, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 18, 2020
Evaluation of mobilization efficacy with an extended interval following plerixafor administrationSarah E Stump, Morgan Trepte, J Ryan Shaw, et al.The Analyst|November 3, 2015
Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from bloodJoshua M Jackson, James B Taylor, Małgorzata A Witek, et al.Leukemia & Lymphoma|April 10, 2009
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survivalThomas C Shea, Anne W Beaven, Dominic T Moore, et al.Life Sciences|March 4, 2000
Evidence that gingko biloba extract does not inhibit MAO A and B in living human brainJ S Fowler, G J Wang, N D Volkow, et al.Neurology|October 1, 1993
Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327J S Fowler, N D Volkow, J Logan, et al.Nucleic Acids Research|February 11, 1992
Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s)P V Danenberg, T Horikoshi, M Volkenandt, et al.Current Medical Research and Opinion|December 17, 2020
Construct validity and reproducibility of the Prescription Opioid Misuse And Abuse Questionnaire (POMAQ)Karin S Coyne, Alexandra I Barsdorf, Brooke M Currie, et al.Endocrinology|June 15, 2018
Knockout of USP19 Deubiquitinating Enzyme Prevents Muscle Wasting by Modulating Insulin and Glucocorticoid SignalingErin S Coyne, Nathalie Bedard, Linda Wykes, et al.Archives of Dermatology|June 1, 1988
Malignant melanoma. Treatment with high-dose combination alkylating agent chemotherapy and autologous bone marrow supportT C Shea, K H Antman, J P Eder, et al.Pageof 48